Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in CKD
NCT01061320Phase 3Unknown
- Sponsor
- Thammasat University
- Start
- Jan 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-tocopherol in contrast-induced nephropathy (CIN), sponsored by Thammasat University. Status: unknown.
02
Drugs
alpha-tocopherol
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01061320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061320.